Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1 integrin monoclonal antibody (volociximab) in cancer patients

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, May 2009

Altmetric Badge

Mentioned by

wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 32 Mendeley

Summary Wikipedia Dimensions citations

So far, Altmetric has seen 2 citations on 2 Wikipedia pages.

Chinese

伏洛昔单抗

Cited by user 微肿头龙 on 20 Jan 2024

伏洛昔单抗（INN：Volociximab；开发代号：M200）是与渤健联合开发的嵌合单克隆抗体，用于治疗多种晚期实体瘤. 它结合并抑制整合素的功能活性.

English

Volociximab

Cited by user Anypodetos on 01 Oct 2009

Volociximab (also known as M200) is a chimeric monoclonal antibody jointly developed by PDL BioPharma and Biogen Idec for treatment of a variety of advanced solid tumors.